An aging‐related signature predicts favorable outcome and immunogenicity in lung adenocarcinoma

Aging has been demonstrated to play vital roles in the prognosis and treatment efficacy of cancers, including lung adenocarcinoma (LUAD). This novel study aimed to construct an aging‐related risk signature to evaluate the prognosis and immunogenicity of LUAD. Transcriptomic profiles and clinical inf...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wenjing, Li, Yuting, Lyu, Juncheng, Shi, Fuyan, Kong, Yujia, Sheng, Chao, Wang, Suzhen, Wang, Qinghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898732/
https://www.ncbi.nlm.nih.gov/pubmed/34967077
http://dx.doi.org/10.1111/cas.15254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898732/
https://www.ncbi.nlm.nih.gov/pubmed/34967077
http://dx.doi.org/10.1111/cas.15254

Ejemplares similares